Lung cancer from suspicion to treatment: An indicator of healthcare access in Turkey

Simple item page
dc.contributor.authorKızılırmak D.
dc.contributor.authorYılmaz Kaya Z.
dc.contributor.authorGökçimen G.
dc.contributor.authorHavlucu Y.
dc.contributor.authorCengiz Özyurt B.
dc.contributor.authorGündoğuş B.
dc.contributor.authorEsendağlı D.
dc.contributor.authorSerez Kaya B.
dc.contributor.authorYılmam İ.
dc.contributor.authorAydemir Y.
dc.contributor.authorÇolak M.
dc.contributor.authorAfşin E.
dc.contributor.authorÇetin N.
dc.contributor.authorİdikut A.
dc.contributor.authorDeğirmenci C.
dc.contributor.authorOral Tapan Ö.
dc.contributor.authorGündüz Gürkan C.
dc.contributor.authorKocatürk C.İ.
dc.contributor.authorÖmeroğlu Şimşek G.
dc.contributor.authorKalafat C.E.
dc.contributor.authorÖzgün Niksarlıoğlu E.Y.
dc.contributor.authorErgün Serdaroğlu M.
dc.contributor.authorKarcıoğlu O.
dc.contributor.authorÖzyurt S.
dc.contributor.authorKarahacıoğlu Madran E.
dc.contributor.authorYaprak Bayrak B.
dc.contributor.authorAlasgarova Z.
dc.contributor.authorBaydar Toprak O.
dc.contributor.authorYılmazel Uçar E.
dc.contributor.authorTopal B.N.
dc.contributor.authorArgun Barış S.
dc.contributor.authorGuliyev E.
dc.contributor.authorGüzel E.
dc.contributor.authorKüçük S.
dc.contributor.authorOcaklı B.
dc.contributor.authorBaran Ketencioğlu B.
dc.contributor.authorSelçuk N.T.
dc.contributor.authorSarı Akyüz M.
dc.contributor.authorSercan Özgür E.
dc.contributor.authorYetkin N.A.
dc.contributor.authorÇetinkaya P.D.
dc.contributor.authorDeniz P.P.
dc.contributor.authorAtlı S.
dc.contributor.authorÇetindoğan H.
dc.contributor.authorKarakaş F.G.
dc.contributor.authorYılmaz E.S.
dc.contributor.authorErgün D.
dc.contributor.authorErgün R.
dc.contributor.authorTulay C.M.
dc.contributor.authorÜnsal M.
dc.contributor.authorDemirkaya İ.
dc.contributor.authorMarım F.
dc.contributor.authorKaya İ.
dc.contributor.authorDemirdöğen E.
dc.contributor.authorGörek Dilektaşlı A.
dc.contributor.authorUrsavaş A.
dc.contributor.authorÇelik P.
dc.date.accessioned2024-07-22T08:02:07Z
dc.date.available2024-07-22T08:02:07Z
dc.date.issued2023
dc.description.abstractBackground: Lung cancer is the leading cause of cancer-related deaths worldwide. Before beginning lung cancer treatment, it is necessary to complete procedures such as suspecting lung cancer, obtaining a pathologic diagnosis, and staging. This study aimed to investigate the processes from suspicion of lung cancer to diagnosis, staging, and treatment initiation. Methods: The study was designed as a multicenter and cross-sectional study. Patients with lung cancer from various health institutions located in all geographic regions of Turkey were included in the study. The sociodemographic and clinical characteristics of the patients, the characteristics of the health institutions and geographic regions, and other variables of the lung cancer process were recorded. The time from suspicion of lung cancer to pathologic diagnosis, radiologic staging, and treatment initiation, as well as influencing factors, were investigated. Results: The study included 1410 patients from 29 different medical centers. The mean time from the initial suspicion of lung cancer to the pathologic diagnosis was 48.0 ± 52.6 days, 39.0 ± 52.7 days for radiologic staging, and 74.9 ± 65.5 days for treatment initiation. The residential areas with the most suspected lung cancer cases were highly developed socioeconomic zones. Primary healthcare services accounted for only 0.4% of patients with suspected lung cancer. The time to pathologic diagnosis was longer in the Marmara region, and the wait time for staging and treatment initiation was longer in Eastern and Southeastern Anatolia. Patients who presented to chest disease referral hospitals with peripheral lesions, those with early-stage disease, and those who were diagnosed surgically had significantly longer wait times. Conclusion: The time between pathologic diagnosis, staging, and treatment initiation in lung cancer was longer than expected. Increasing the role of primary healthcare services and distributing socioeconomic resources more equally will contribute to shortening the time to diagnosis and improve treatment processes for lung cancer. © 2023 Elsevier Ltd
dc.identifier.DOI-ID10.1016/j.canep.2023.102480
dc.identifier.issn18777821
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/11726
dc.language.isoEnglish
dc.publisherElsevier Ltd
dc.subjectCross-Sectional Studies
dc.subjectHealth Services Accessibility
dc.subjectHumans
dc.subjectLung Neoplasms
dc.subjectNeoplasm Staging
dc.subjectTurkey
dc.subjectantineoplastic agent
dc.subjectadult
dc.subjectArticle
dc.subjectcancer chemotherapy
dc.subjectcancer immunotherapy
dc.subjectcancer palliative therapy
dc.subjectcancer patient
dc.subjectcancer radiotherapy
dc.subjectcancer staging
dc.subjectcancer surgery
dc.subjectchemoradiotherapy
dc.subjectclinical feature
dc.subjectcross-sectional study
dc.subjectdemography
dc.subjectdiagnosis time
dc.subjectfemale
dc.subjecthealth care access
dc.subjecthuman
dc.subjecthuman tissue
dc.subjectlung cancer
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmiddle aged
dc.subjectmolecularly targeted therapy
dc.subjectmulticenter study
dc.subjectnon small cell lung cancer
dc.subjectpatient referral
dc.subjectprimary health care
dc.subjectresidential area
dc.subjectsocial status
dc.subjectTurkey (republic)
dc.subjectclinical trial
dc.subjecthealth care access
dc.subjectlung tumor
dc.subjectturkey (bird)
dc.titleLung cancer from suspicion to treatment: An indicator of healthcare access in Turkey
dc.typeArticle

Files

Collections

Scopus Koleksiyonu